Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation

Conclusions: Observational studies on metformin and cancer varied in design, and the majority were at risk of a range of biases. The studies least likely to be affected by bias did not support a causal effect of metformin on cancer risk.
Source: International Journal of Epidemiology - Category: Epidemiology Source Type: research